This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: The Innovations of Stephen W. Mamber
Introduction
Stephen W. Mamber is an accomplished inventor based in Ann Arbor, MI. He is known for his significant contributions to the field of antimicrobial and antitumor research. His work has led to the development of innovative compounds that demonstrate promising biological activities.
Latest Patents
Mamber holds a patent for "Antimicrobial and antitumor phenazine carboxaldehydes and derivatives." This patent includes acids, esters, imine acids, imine esters, and imine amides derived from 6-formyl-4,7,9-trihydroxy-1-phenazinecarboxylic acid, methyl ester, and from 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester. These compounds exhibit antimicrobial and antineoplastic activity. A purified strain of Streptomyces galanosa, NRRL 15738, is capable of producing 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester in isolable quantities from a fermentation broth containing assimilable sources of carbon and nitrogen.
Career Highlights
Mamber has made significant strides in his career, particularly through his work at Warner-Lambert Company. His research has focused on developing new therapeutic agents that can combat various diseases, showcasing his dedication to improving public health.
Collaborations
Throughout his career, Mamber has collaborated with notable colleagues, including Christopher Franklin Bigge and Edward Faith Elslager. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.
Conclusion
Stephen W. Mamber's contributions to antimicrobial and antitumor research highlight his role as a leading inventor in the field. His innovative work continues to pave the way for new therapeutic options that can benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile